- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Baxter International Inc.
Headquarters: Deerfield, IL, United States of America
Website: http://www.baxter.com
Year Founded: 1931
Status: Public
Industry Sector: HealthTechnology
CEO: D. Brent Shafer, MD
Number Of Employees: 38,000
Enterprise Value: $26,614,600,000
PE Ratio: -27.17
Exchange/Ticker 1: NYSE:BAX
Exchange/Ticker 2: N/A
Latest Market Cap: $17,676,644,352
BioCentury | Mar 7, 2025
Management Tracks
Abbas Kazimi succeeds Jeb Keiper as CEO of Nimbus
Plus: Jon Garay Alonso named CFO of Almirall, and updates from Certara and Immunai
BioCentury | Apr 16, 2024
Management Tracks
Viatris hires Corinne Le Goff as commercial head
Plus: Exact, Obsidian name new CFOs and updates from Applied, Faron, Athira and more
BioCentury | May 9, 2023
Deals
May 8 Quick Takes: EQRx reset brings end of China deals, layoffs
Plus: Legend’s $350M raise helps May follow-ons top April tally; ADC deals by Eisai-BlissBio, FibroGen-Fortis; and more
BioCentury | Mar 28, 2023
Finance
Sofinnova Partners’ digital strategy to address ‘sea change’ in data, computation and biology
Pair of partners to lead firm’s sixth official strategy backing start-ups with healthcare-enabling tech, analytics and digital therapeutics
BioCentury | Jan 31, 2023
Management Tracks
Baxter’s Accogli named CEO of Chiesi
Plus: J&J CMO Waldstreicher retiring, and updates from the Broad Institute, Ring, Hansa, Vaccitech and Beyond Air
BioCentury | Mar 9, 2022
Management Tracks
Oxford spinout MiroBio adds Keswani as CMO, promotes Murray to CSO
Plus updates from Centessa, Teon, AnchorDx, Pillar and more
BioCentury | Jan 21, 2022
Emerging Company Profile
ImmPACT: uniting CAR T platforms for ‘logic-gate’ therapies
Los Angeles-area biotech has $111M series B, early clinical data in hand as it advances bispecific CAR T
BioCentury | Oct 6, 2021
Management Tracks
Weinstein becomes CFO at Caris Life Sciences
Plus: Kezar, PDS, aTyr, Rosewell, Orum and more
BioCentury | Sep 9, 2021
Management Tracks
Hayes joins Fulcrum as chief commercial officer
Plus: ImmunityBio, Finch, Rhythm, Infinity, Locanabio and more
BioCentury | Feb 5, 2021
Product Development
Big shoes: Davis needs to fill Merck’s post-Keytruda pipeline as Frazier shifts to executive chair
Focus will be on modest, early-stage deals as the pharma seeks next blockbuster
Items per page:
1 - 10 of 655